Cytotoxic action of adenosine nucleoside and dialdehyde analogues on murine neuroblastoma in tissue culture: structure-activity relationships.

Abstract:

:A series of purine nucleoside and dialdehyde analogues was studied to determine their potency as inhibitors of C-1300 murine neuroblastoma cell growth in tissue culture. Tumor cells were incubated with each analogue for 72 h, and the number of viable cells was determined at 24, 48, and 72 h. Dose-response curves were generated (concentration range, 10(-8) to 10(-3) M), and the drug concentration producing 50% inhibition of cell growth was calculated for each analogue. The 50% inhibitory concentrations, in ascending order of potency, were as follows: adenosine (inactive); S-adenosylhomocysteine (inactive); methylfuryladenine (5.6 X 10(-1)M); adenosine 5'-carboxylic acid (2.0 X 10(-1)M); 5'-chloro, 5'-deoxy-ara-adenosine (3.0 X 10(-2)M); sinefungin (1.7 X 10(-3) M); 5'-deoxyadenosine (2.2 X 10(-4)M); 5'-chloro, 5'-deoxyadenosine (2.1 X 10(-4)M); 3',5'-dichloro, 2',3',5'-trideoxyadenosine (1.3 X 10(-4)M); 3-deazaadenosine (5.6 X 10(-5)M); and adenosine dialdehyde (1.5 X 10(-6)M). Oxidation of the pentose to a dialdehyde increased, whereas reduction of the dialdehyde or substitution of adenine with either hypoxanthine, guanine, uracil, or cytosine decreased the inhibitory potency. The analogues 4',5'-anhydroadenosine dialdehyde and 5'-deoxyadenosine dialdehyde, which cannot be phosphorylated at the 5' position, had 50% inhibitory concentrations of 9.1 X 10(-6) and 7.6 X 10(-6)M, respectively. These data suggest that the inhibitory action and potency of nucleoside dialdehydes on neuroblastoma growth are independent of their capacity to undergo a kinase-mediated phosphorylation at the 5' position.

journal_name

Cancer Res

journal_title

Cancer research

authors

Mirkin BL,O'Dea RF,Hogenkamp HP

subject

Has Abstract

pub_date

1987-07-15 00:00:00

pages

3650-5

issue

14

eissn

0008-5472

issn

1538-7445

journal_volume

47

pub_type

杂志文章
  • Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding.

    abstract::Mesothelin is a cell-surface tumor-associated antigen expressed in several human cancers. The limited expression of mesothelin on normal tissues and its high expression in many cancers make it an attractive candidate for targeted therapies using monoclonal antibodies, immunoconjugates, and immunotoxins. Mesothelin is ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-0466

    authors: Zhang Y,Chertov O,Zhang J,Hassan R,Pastan I

    更新日期:2011-09-01 00:00:00

  • Cancer induction in mice by feeding of the uncooked cultivated mushroom of commerce Agaricus bisporus.

    abstract::The cultivated mushroom of commerce in the Western hemisphere, Agaricus bisporus, was given p.o. to randomly bred Swiss mice for 3 days and was followed by semisynthetic diet for 4 days each week for life. The mice were 6 weeks old at the beginning of the experiment. As a result of treatment, tumors were induced in th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Toth B,Erickson J

    更新日期:1986-08-01 00:00:00

  • Cell surface changes in HeLa cells as an indication of cell cycle events.

    abstract::A HeLa cell line synchronized by double thymidine block and mitotic shake off was shown to have a characteristic surface morphology for each of the different cell cycle stages. Inhibitors of cell multiplication were used to arrest cells in specific cell cycle phases, and these cells had a surface morphology similar to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lundgren E,Roos G

    更新日期:1976-11-01 00:00:00

  • Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.

    abstract::The p75 and p110 isoforms of the CUX1 homeodomain protein are overexpressed in breast tumors and cancer cell lines. To assess and compare the ability of these short CUX1 isoforms in driving mammary tumor development, we used site-specific transgenesis into the Hprt locus to generate transgenic mice expressing p75 or p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4899

    authors: Cadieux C,Kedinger V,Yao L,Vadnais C,Drossos M,Paquet M,Nepveu A

    更新日期:2009-09-15 00:00:00

  • Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.

    abstract::Patients with disseminated Ewing's family of tumors (ESFT) often experience drug-resistant relapse. We hypothesize that targeting minimal residual disease with the cytotoxic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR; fenretinide) may decrease relapse. We determined the following: (a) 4-HPR cytotoxicity against 12...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0377

    authors: Batra S,Reynolds CP,Maurer BJ

    更新日期:2004-08-01 00:00:00

  • Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research.

    abstract::Development of novel approaches for quantitative analysis of gene expression in intact tumor cells should provide new means for cancer detection and for studying the response of cancer cells to biological and therapeutic reagents. We developed procedures for detecting the levels of expression of multiple genes in fixe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3196

    authors: Peng XH,Cao ZH,Xia JT,Carlson GW,Lewis MM,Wood WC,Yang L

    更新日期:2005-03-01 00:00:00

  • Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.

    abstract::Micropthalmia transcription factor (Mitf) is involved in melanocyte development and differentiation. The current study was undertaken to determine whether there is a relationship between Mitf expression and survival in patients with intermediate-thickness (1.0-4.0 mm) melanoma. Original paraffin blocks or slides of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Salti GI,Manougian T,Farolan M,Shilkaitis A,Majumdar D,Das Gupta TK

    更新日期:2000-09-15 00:00:00

  • Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.

    abstract::The AP-2 transcription factors are required for normal growth and morphogenesis during mammalian development. Previous in vitro studies have also indicated that the AP-2 family of proteins may be involved in the etiology of human breast cancer. The AP-2 genes are expressed in many human breast cancer cell lines, and c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Turner BC,Zhang J,Gumbs AA,Maher MG,Kaplan L,Carter D,Glazer PM,Hurst HC,Haffty BG,Williams T

    更新日期:1998-12-01 00:00:00

  • Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells.

    abstract::Increased expression of cyclooxygenase (COX) and overproduction of prostaglandins (PGs) have been implicated in the development and progression of colorectal cancer (CRC). Nonsteroidal anti-inflammatory agents (NSAIDS) inhibit growth of various CRC cell lines by both COX-dependent and COX-independent pathways. To spec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chinery R,Coffey RJ,Graves-Deal R,Kirkland SC,Sanchez SC,Zackert WE,Oates JA,Morrow JD

    更新日期:1999-06-01 00:00:00

  • Overexpression of mitochondrial manganese superoxide dismutase protects against radiation-induced cell death in the human hepatocellular carcinoma cell line HLE.

    abstract::We investigated the potential role of mitochondrial manganese superoxide dismutase (Mn-SOD) in protective activity against irradiation by analyzing cell viability by a colony formation assay and by detecting apoptosis in stably human Mn-SOD gene-transfected HLE, a hepatocellular carcinoma cell line. We found that over...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Motoori S,Majima HJ,Ebara M,Kato H,Hirai F,Kakinuma S,Yamaguchi C,Ozawa T,Nagano T,Tsujii H,Saisho H

    更新日期:2001-07-15 00:00:00

  • Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.

    abstract::Preclinical studies have suggested that β-adrenergic signaling is involved in pancreatic cancer progression. Prompted by such studies, we investigated an association between beta-blocker drug use with improved cancer-specific survival in a large, general population-based cohort of patients with pancreatic ductal adeno...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0108

    authors: Udumyan R,Montgomery S,Fang F,Almroth H,Valdimarsdottir U,Ekbom A,Smedby KE,Fall K

    更新日期:2017-07-01 00:00:00

  • Estramustine depolymerizes microtubules by binding to tubulin.

    abstract::To investigate the mechanism of action of the antineoplastic drug estramustine, we compared its effects on human prostate cancer cells with those of vinblastine. At their respective concentrations that result in 50% inhibition of clonogenic growth, both drugs caused an accumulation of cells blocked at mitosis and simi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dahllöf B,Billström A,Cabral F,Hartley-Asp B

    更新日期:1993-10-01 00:00:00

  • ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.

    abstract::The use of targeted therapeutics directed against BRAF(V600)-mutant metastatic melanoma improves progression-free survival in many patients; however, acquired drug resistance remains a major medical challenge. By far, the most common clinical resistance mechanism involves reactivation of the MAPK (RAF/MEK/ERK) pathway...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2073

    authors: Goetz EM,Ghandi M,Treacy DJ,Wagle N,Garraway LA

    更新日期:2014-12-01 00:00:00

  • Paracrine stimulation of polarized secretion from monolayers of a neoplastic prostatic epithelial cell line by prostatic stromal cell proteins.

    abstract::The paracrine influence of prostatic stromal cell proteins on a neoplastic prostate cell line (PA-III) was investigated. We have utilized an in vitro experimental model whereby confluent epithelial sheets of PA-III cells are grown on Matrigel-coated filters in bicameral chambers (Millicell-HA). Confluence of the epith...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Djakiew D,Tarkington MA,Lynch JH

    更新日期:1990-03-15 00:00:00

  • The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models.

    abstract::The proto-oncogene MET is aberrantly activated via overexpression or mutation in numerous cancers, making it a prime anticancer molecular target. However, the clinical success of MET-directed tyrosine kinase inhibitors (TKI) has been limited due, in part, to mutations in the MET kinase domain that confer therapeutic r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1156

    authors: Miyajima N,Tsutsumi S,Sourbier C,Beebe K,Mollapour M,Rivas C,Yoshida S,Trepel JB,Huang Y,Tatokoro M,Shinohara N,Nonomura K,Neckers L

    更新日期:2013-12-01 00:00:00

  • Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2.

    abstract::Neurofibromatosis type 2 (NF2) is a dominantly inherited cancer disorder caused by mutations at the NF2 gene locus. Merlin, the protein product of the NF2 gene, has been shown to negatively regulate Rac1 signaling by inhibiting its downstream effector kinases, the p21-activated kinases (Pak). Given the implication of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0866

    authors: Yi C,Wilker EW,Yaffe MB,Stemmer-Rachamimov A,Kissil JL

    更新日期:2008-10-01 00:00:00

  • CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.

    abstract::CXCL10 was recently shown to exert antimalignancy functions by influencing the tumor microenvironment. Here, we have taken a different approach, investigating the effects of CXCL10 directly on tumor-promoting functions in colorectal carcinoma (CRC) cells. CXCL10 expression was detected in preferred metastatic sites of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3087

    authors: Zipin-Roitman A,Meshel T,Sagi-Assif O,Shalmon B,Avivi C,Pfeffer RM,Witz IP,Ben-Baruch A

    更新日期:2007-04-01 00:00:00

  • Relationship between a tumor promoter-induced decrease in queuine modification of transfer RNA in normal human cells and the expression of an altered cell phenotype.

    abstract::With normal human skin fibroblasts in culture, a transient decrease in queuine modification of tRNA precedes a phorbol ester tumor promoter-induced 5- to 10-fold increase in saturation density. Subsequently, an increase in the queuine content of cellular tRNA (to levels comparable to those in untreated cultures) prece...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Elliott MS,Katze JR,Trewyn RW

    更新日期:1984-08-01 00:00:00

  • 3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans.

    abstract::Because chronic intestinal inflammation is a risk factor for colorectal cancer, we hypothesized that genetic variants of inflammatory mediators, such as mannose-binding lectin 2 (MBL2), are associated with colon cancer susceptibility. Here, we report the association of 24 MBL2 single-nucleotide polymorphisms (SNP) and...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3073

    authors: Zanetti KA,Haznadar M,Welsh JA,Robles AI,Ryan BM,McClary AC,Bowman ED,Goodman JE,Bernig T,Chanock SJ,Harris CC

    更新日期:2012-03-15 00:00:00

  • Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate.

    abstract::The high uptake and prolonged renal retention of monoclonal antibody fragments that are conjugated with radiometal chelates precludes their routine clinical use due to high background counts, which may hinder detection of nearby lesions and/or cause renal radiotoxicity. We report on the potential use of Lys as a pharm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: DePalatis LR,Frazier KA,Cheng RC,Kotite NJ

    更新日期:1995-11-15 00:00:00

  • ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates.

    abstract::ABCG2 is an ATP-binding cassette transporter that confers resistance to various chemotherapeutic agents. Recent studies have established that an Arg (wild-type) to Gly mutation at amino acid 482 in ABCG2 alters substrate specificity. Here, we explored the role of this G482 mutation in antifolate resistance using a cli...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-4547

    authors: Shafran A,Ifergan I,Bram E,Jansen G,Kathmann I,Peters GJ,Robey RW,Bates SE,Assaraf YG

    更新日期:2005-09-15 00:00:00

  • Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts.

    abstract::We have previously shown that topotecan, a topoisomerase I poison, inhibits hypoxia-inducible factor (HIF)-1alpha protein accumulation by a DNA damage-independent mechanism. Here, we report that daily administration of topotecan inhibits HIF-1alpha protein expression in U251-HRE glioblastoma xenografts. Concomitant wi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2116

    authors: Rapisarda A,Zalek J,Hollingshead M,Braunschweig T,Uranchimeg B,Bonomi CA,Borgel SD,Carter JP,Hewitt SM,Shoemaker RH,Melillo G

    更新日期:2004-10-01 00:00:00

  • Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.

    abstract::In this report, we describe the immunomodulatory characteristics of poly(I,C)-LC, a synthetic, double-stranded nucleic acid polymer, polyinosinic-polycytidylic acid, that is complexed with poly-L-lysine and solubilized by the addition of carboxymethylcellulose. We consistently observed, both in vitro and in vivo, stim...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Talmadge JE,Adams J,Phillips H,Collins M,Lenz B,Schneider M,Schlick E,Ruffmann R,Wiltrout RH,Chirigos MA

    更新日期:1985-03-01 00:00:00

  • Effects of transferrin-indium on cellular proliferation of a human leukemia cell line.

    abstract::In previous studies, we have demonstrated that transferrin-gallium inhibits cellular proliferation by a mechanism whereby cellular iron utilization is impaired. Since indium, a similar class 3A metal, has not been well studied, we examined its effects on cellular iron uptake and cellular proliferation. In these studie...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Moran PL,Seligman PA

    更新日期:1989-08-01 00:00:00

  • Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates.

    abstract::To enable antibodies to function as cytotoxic anticancer agents, they are modified either via attachment to protein toxins or highly potent, low-molecular-weight drugs. Such molecules, termed immunotoxins and antibody-drug conjugates, respectively, represent a second revolution in antibody-mediated cancer therapy. Thu...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-11-1374

    authors: FitzGerald DJ,Wayne AS,Kreitman RJ,Pastan I

    更新日期:2011-10-15 00:00:00

  • Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice.

    abstract::One-week-old male and female mice of the A, BALB/c (C), and C3H/He (C3) strains and of the AC3 and CC3 F1 hybrids were treated with a single dose (300 mg/kg s.c.) of urethan and then kept without further treatment until 30 and 40 weeks (males) or 30 and 65 weeks (females). The degree of difference in susceptibility to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dragani TA,Manenti G,Della Porta G

    更新日期:1991-12-01 00:00:00

  • Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.

    abstract::Mitogen-activated protein kinases function in signal transduction pathways that are involved in controlling key cellular processes in many organisms. A mammalian member of this kinase family, MKK4/JNKK1/SEK1, has been reported to link upstream MEKK1 to downstream stress-activated protein kinase/JNK1 and p38 mitogen-ac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Teng DH,Perry WL 3rd,Hogan JK,Baumgard M,Bell R,Berry S,Davis T,Frank D,Frye C,Hattier T,Hu R,Jammulapati S,Janecki T,Leavitt A,Mitchell JT,Pero R,Sexton D,Schroeder M,Su PH,Swedlund B,Kyriakis JM,Avruch J,Bar

    更新日期:1997-10-01 00:00:00

  • Biological consequences of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells.

    abstract::In order to examine the effects of the overexpression of c-erbB-2 (HER-2, neu) on human bronchial epithelial cells, a human c-erbB-2 expression vector was introduced into the simian virus 40 large T-antigen-immortalized human bronchial epithelial cell line BEAS-2B. Isolation of multiple clonal cell lines after selecti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Noguchi M,Murakami M,Bennett W,Lupu R,Hui F Jr,Harris CC,Gerwin BI

    更新日期:1993-05-01 00:00:00

  • Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.

    abstract::The mammalian target of rapamycin (mTOR) has been shown to link growth factor signaling and posttranscriptional control of translation of proteins that are frequently involved in cell cycle progression. However, the role of this pathway in cell survival has not been demonstrated. Here, we report that rapamycin, a spec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hosoi H,Dilling MB,Shikata T,Liu LN,Shu L,Ashmun RA,Germain GS,Abraham RT,Houghton PJ

    更新日期:1999-02-15 00:00:00

  • MFF Regulation of Mitochondrial Cell Death Is a Therapeutic Target in Cancer.

    abstract::The regulators of mitochondrial cell death in cancer have remained elusive, hampering the development of new therapies. Here, we showed that protein isoforms of mitochondrial fission factor (MFF1 and MFF2), a molecule that controls mitochondrial size and shape, that is, mitochondrial dynamics, were overexpressed in pa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1982

    authors: Seo JH,Chae YC,Kossenkov AV,Lee YG,Tang HY,Agarwal E,Gabrilovich DI,Languino LR,Speicher DW,Shastrula PK,Storaci AM,Ferrero S,Gaudioso G,Caroli M,Tosi D,Giroda M,Vaira V,Rebecca VW,Herlyn M,Xiao M,Fingerman D,Ma

    更新日期:2019-12-15 00:00:00